[Advances in the treatment of osteoporosis (author's transl)]
- PMID: 7101948
[Advances in the treatment of osteoporosis (author's transl)]
Abstract
Osteoporosis is not a disease in itself and, hence, the management and prognosis in any individual case depends on the aetiology. Other important factors determining treatment are the extent of the osteoporotic changes, the age and sex of the patient, the severity of the symptoms and the complications. The paramount aim of therapy is to arrest the osteoporotic process by selective treatment of the underlying cause of bone rarefication and, if possible, to achieve compensatory strengthening of the remaining skeletal structure by stimulating the formation of new bone.
Similar articles
-
[Current research in therapy of postmenopausal osteoporosis (author's transl)].Sem Hop. 1979 Feb 18-25;55(7-8):325-9. Sem Hop. 1979. PMID: 220722 Review. French.
-
[Principles in the therapy of osteoporosis. 2. Therapy].Fortschr Med. 1977 Feb 24;95(8):446-70. Fortschr Med. 1977. PMID: 856703 German.
-
[Current treatment of osteoporosis].Rev Med Suisse Romande. 1991 Oct;111(10):885-9. Rev Med Suisse Romande. 1991. PMID: 1772520 Review. French. No abstract available.
-
[Therapy of old-age osteoporosis].Dtsch Med Wochenschr. 1977 Aug 19;102(33):1186, 1193-6. Dtsch Med Wochenschr. 1977. PMID: 330133 Review. German. No abstract available.
-
Treatment of postmenopausal osteoporosis.Compr Ther. 1984 Jul;10(7):41-7. Compr Ther. 1984. PMID: 6744804 No abstract available.
Cited by
-
Sex-hormone-binding globulin is negatively correlated with femoral bone-mineral density in male cardiac-transplant recipients.Wien Klin Wochenschr. 2004 Mar 31;116(5-6):170-5. doi: 10.1007/BF03040483. Wien Klin Wochenschr. 2004. PMID: 15088991 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical